
Please try another search
Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as oral rehydration therapy supplement for urinary tract. It engages in the trading of pharmaceutical products, nutritional foods, and medical equipment. Further, the company provides medical devices, including Made in Germany CE-marked drug-eluting coronary stents, PTCA balloon catheters, and other coronary angioplasty accessories and electrophysiology products. Otsuka Pakistan Limited was incorporated in 1988 and is headquartered in Karachi, Pakistan.
Name | Age | Since | Title |
---|---|---|---|
Mikio Bando | - | 2016 | Chairman |
Moin-ur Rehman | - | 2023 | CEO, GM of Marketing & Medical Devices and Director |
Abid Hussain | - | 2021 | Independent Director |
Suhari Mukti | - | 2016 | Non-Executive Director |
Tariq Mehtabuddin Feroz | - | 2024 | Director |
Navin Salim Merchant | - | 2018 | Independent Director |
Muhammad Taufiq Feroz | - | 2021 | Alternate Director |
Hideshi Tsunezawa | - | 2024 | Alternate Director |
Sajid Ali Khan | - | 2024 | Alternate Director |
Naito Kimitaka | - | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review